Memorial Sloan Kettering, Atara Biotherapeutics deal

In September, Atara paid Memorial Sloan Kettering $1.3 million in cash and issued 59,761

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE